2Kopparapu PK, Boorjian SA, Robinson BD, et al. Expres sion of VEGF and its receptors VEGFR1/VEGFR2 is as sociated with invasiveness of bladder Caneer[J]. Antican cer Res,2013,33(6) .2381-2390.
3Kozzowski M, Laudaflski W, Mroczko B, et al. Serum tis sue inhibitor of metalloproteinase 1 (TIMP-1) and vascu- lar endothelial growth factor A(VEGF-A) are associated with prognosis in esophageal Cancer patients E J. Adv Med Sci,2013,18 . 1-8.
4Xu XL, Ling ZQ, Chen W, et al. The overexpression of VEGF in esophageal Cancer is associated with a more ad- vanced TMN stage: a meta-analysis[J]. Cancer Biomark, 2013,13(2) :105-113.
5Wolaflska M, Maflkowski A, Romanowicz L, et al. Does vascular endothelial growth factor participate in uterine myoma growth stimulation[J]. Eur J Obstet Gynecol Re- prod Biol, 2012,164(1) . 93-97.
6Chang CC, Hsieh YY, Lin WH, et al. Leiomyoma and vas- cular endothelial growth factor gene polymorphisms., a systematic review[J]. Taiwan J Obstet Gynecol, 2010,49 (3):247 253.
7Zhao S, Ma D, Dai H, et al. Biologically inhibitory e[fects of VEGF siRNA on endometrial carcinoma cells(-J. Arcb Gynecol Obstet, 2011,284(6) : 1533-1541.
8Guset G, Costi S, Laz8r E, et al. Expression of vascular endothelial growth factor(VEGF) and assessment of mi- crovascular density with CD34 as prognostic markers for endometrial carcinoma Jl. Rom J Morpbol Embryol, 2010,51(4) :677-682.
9Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, et al. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian Cancer E J. Eur Cytokine Netw,2013,24(3) : 106-113.
10He G, Dhar D, Nakagawa H, et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling [J]. Cell, 2013,165 ( 2 ) : 384 396.
